- Investors
Annual General Shareholders Meeting
Today, we held our Annual General Meeting of Shareholders, reflecting on our continued momentum and steady progress toward our ambition of becoming a global leader in medical dermatology.
Investors
Our commitment to science and innovation drives our purpose
Shareholder information
Consult this section for comprehensive details on share performance, dividends and other financial matters. This data is provided for information purposes only.
Investors update
Latest updates on the company’s financial performance, partnerships, and strategic initiatives, offering investors and stakeholders clear insights into the developments shaping future growth.
1/3
- Investors
Financial Results Q1 2026
Today, we shared our financial results for the first quarter of 2026, continuing our positive trajectory and delivering performance in line with expectations and our long-term growth strategy.
- Investors
Financial Results Q1 2026
Today, we shared our financial results for the first quarter of 2026, continuing our positive trajectory and delivering performance in line with expectations and our long-term growth strategy.
- Investors
Annual General Shareholders Meeting
Today, we held our Annual General Meeting of Shareholders, reflecting on our continued momentum and steady progress toward our ambition of becoming a global leader in medical dermatology.
- Investors
Almirall meets 2025 guidance, delivering 12.4% net sales growth and continued pipeline progress
Our Full Year Financial Results confirmed that we sustained a solid growth trajectory in 2025, meeting our full‑year guidance and underscoring our leadership in medical dermatology.
Financial data
Find and download Almirall's financial information
9M 2025 financial results presentation
PDF 1.1MB
consolidated accounts H1 2025
PDF 1.1MB
H1 2025 financial results presentation
PDF 978.5KB
Q1 2025 financial results presentation
PDF 1.4MB
Almirall’s leadership and governance
Our structure
As a publicly listed company and for the benefit of both the financial markets and the general public, Almirall pursues an open and active information policy.
Contact us
Pablo Divasson del Fraile
Investors relations
Ronda General Mitre, 151 - 08022 Barcelona
T+ 34 932 913 000
